Medical-Grade Nutrition · Metabolic Safety · Global Deployment

Lathell Nutraceuticals

Lathell Nutraceuticals is building a global technology platform focused on medical-grade nutrition, safer metabolic systems, ingredient innovation, and future physiological intelligence technologies.

Our lead commercial platform, SAFE SUGAR, is positioned as a very-low-glycemic ingredient technology for large-scale food manufacturing, institutional nutrition systems, and procurement-aligned deployment. Alongside it, Lathell is advancing broader platform technologies including OMNIPHYX, BSS Advanced, BioAge, and GlassFind.

The model is direct: develop technologies with commercial relevance, structure them for licensing and validation, and scale through strategic partners, distributors, and institutional adoption channels in high-impact regions.

Explore SAFE SUGAR View Market Opportunity Licensing & Partnerships

Flagship Platforms

Technology Platforms

SAFE SUGAR

Very-low-glycemic sweetener platform for food manufacturing, institutional nutrition, and metabolic-health deployment.

SAFE CARBS

Carb-safety reformulation direction aligned with Lathell’s broader metabolic-health platform strategy.

OMNIPHYX

Physiological intelligence ecosystem for biosignal interpretation and future health-technology systems.

BSS Advanced

Bio-Signal Stability Scanner platform for monitoring, resilience tracking, and advanced analytics.

BioAge

Longevity and biological-age assessment platform aligned with preventive health positioning.

GlassFind

Detection concept for microscopic upper-tissue particles that conventional imaging can miss.

Procurement Ready

Designed for institutional adoption and structured deployment.

Reproducible Systems

Built for consistent application across regions and partners.

Population Health Impact

Focused on reducing chronic disease burden and metabolic risk.

Global Deployment

Built for pilot programs, procurement pathways, licensing, and scale.

Institutional-first positioning

Focused on ministries, healthcare systems, institutional buyers, and procurement-aligned adoption pathways.

Global partner expansion

Built to expand through manufacturers, distributors, universities, and strategic collaboration channels.

Funding-aligned deployment

Pilots, licensing, validation, procurement, and commercialization structured to connect with funding and scaled purchasing.

Lathell Global Technology Ecosystem

Lathell Nutraceuticals is building an integrated portfolio of technology platforms focused on metabolic health innovation, next-generation ingredient systems, physiological intelligence, and scalable commercialization pathways designed for global deployment.

SAFE SUGAR

Very-low-glycemic crystalline sweetener platform designed for large-scale food manufacturing, institutional nutrition systems, and metabolic-health-focused reformulation.

Explore SAFE SUGAR

OMNIPHYX

Physiological intelligence platform designed to analyze human biosignals and support future monitoring, interpretation, and integrated health-technology systems.

Explore OMNIPHYX™

Technology Platforms

Master overview of Lathell’s integrated technology architecture, including ingredient platforms, biosignal systems, and broader health innovation directions.

View Technology Platforms

Global Market Opportunity

Strategic view of the large-scale commercial opportunity behind next-generation very-low-glycemic ingredient platforms and healthier food-system reformulation.

View Market Opportunity

Licensing & Partnerships

Information for manufacturers, institutions, investors, and strategic collaborators interested in pilots, licensing, validation, and commercialization pathways.

Explore Partnerships

Commercialization Pathways

Lathell Nutraceuticals is building technologies intended for scalable commercial deployment through licensing, strategic manufacturing alignment, institutional programs, partner-led validation, and procurement-linked expansion.

Licensing

Commercialization through qualified strategic manufacturers and ingredient partners.

Institutional deployment

Hospital, public-health, procurement, and large-scale institutional nutrition pathways.

Pilot validation

Evaluation, application testing, and commercialization-readiness work with aligned partners.

Global expansion

Distributor, importer, partner, and funding-aligned rollout into high-impact regions.

Core Technologies

SAFE SUGAR™ is Lathell’s very-low-glycemic sweetener platform designed for metabolic health, institutional nutrition, and food-system applications.

OMNIPHYX™ is Lathell’s physiological intelligence platform designed to support advanced system-level health technology applications.

BSS™ is the Bio-Signal Stability Scanner, a technology platform developed to support advanced physiological signal and device-based innovation.